US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Astellas Pharma, Inc.

14.90

0.0000

Volume:5.00

Turnover:78.89

Market Cap:27.74B

PE:200.40

High:14.90

Open:14.90

Low:14.90

Close:14.90

52wk High:14.90

52wk Low:8.41

Shares:1.86B

Float Shares:1.73B

Volume Ratio:0.01

T/O Rate:NaN%

Dividend:0.50

Dividend Rate:3.38%

EPS(TTM):0.0744

EPS(LYR):0.0628

ROE:19.82%

ROA:7.38%

PB:2.47

PE(LYR):237.11

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Astellas Pharma, Inc.

Exchange:

PINK LIMITED

Establishment Date:

1923

Employees:

13643

Office Location:

2-5-1, Nihonbashi-Honcho,Chuo,Tokyo,Japan

Website:

http://www.astellas.com/en/index.html

Zip Code:

103-8411

Phone:

Fax:

- -

Introduction:

Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALPMF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALPMF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMF\",,,,,undefined,":{"symbol":"ALPMF","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":14.9,"timestamp":1770392195734,"preClose":14.9,"halted":0,"volume":5,"delay":15,"changeRate":0,"floatShares":1731101601,"shares":1861787075,"eps":0.074352,"marketStatus":"Market Closed","change":0,"latestTime":"02-06 10:36:35 EST Delay","open":14.9,"high":14.9,"low":14.9,"amount":78.8875,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":14.9,"volumeRatio":0.01496110248005109},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMF\",,,,,undefined,":{"symbol":"ALPMF","floatShares":1731101601,"roa":"7.38%","roe":"19.82%","lyrEps":0.062841,"volumeRatio":0.01496110248005109,"shares":1861787075,"dividePrice":0.503849,"high":14.9,"amplitude":0,"preClose":14.9,"low":14.9,"week52Low":8.405,"pbRate":"2.47","psRate":"2.12","week52High":14.9,"institutionHeld":0,"latestPrice":14.9,"eps":0.074352,"divideRate":0.033815,"volume":5,"delay":15,"ttmEps":0.074352,"open":14.9,"prevYearClose":13.17,"prevWeekClose":13.9383,"prevMonthClose":13.9383,"prevQuarterClose":13.17,"fiveDayClose":13.9383,"twentyDayClose":13.95,"sixtyDayClose":11.075},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALPMF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-04-25","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-01","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1698811200000,"reportTimeType":"","actualEps":null},{"date":"2023-09-28","symbol":"ALPMF","amount":35,"announcedDate":"2023-07-19","type":"dividend","market":"US","newRecordDate":"2023-09-30","defaultRemindTime":1695907800000,"name":"Astellas Pharma, Inc.","recordDate":"2023-12-01","payableDate":"2023-09-30","currency":"JPY","dateTimestamp":1695873600000,"payDate":"2023-12-01"},{"market":"US","date":"2023-08-01","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1690862400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALPMF\",market:\"US\",,,undefined,":[{"executeDate":"2019-03-27","recordDate":"2019-03-31","paymentDate":"2019-06-18","value":19,"currency":"JPY"},{"executeDate":"2019-09-27","recordDate":"2019-09-30","paymentDate":"2019-12-03","value":20,"currency":"JPY"},{"executeDate":"2020-03-30","recordDate":"2020-03-31","paymentDate":"2020-06-19","value":20,"currency":"JPY"},{"executeDate":"2020-09-29","recordDate":"2020-09-30","paymentDate":"2020-12-01","value":21,"currency":"JPY"},{"executeDate":"2021-03-30","recordDate":"2021-03-31","paymentDate":"2021-06-01","value":21,"currency":"JPY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALPMF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":874641,"yearFounded":1923,"employeeNum":13643,"address":"2-5-1, Nihonbashi-Honcho,Chuo,Tokyo,Japan","zipCode":"103-8411","officePhone":"81 3 3244 3000"},"stockCompanyDetail":{"websiteUrl":"http://www.astellas.com/en/index.html","stockEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.0549},{"period":"3month","weight":-0.0236},{"period":"6month","weight":-0.0147},{"period":"1year","weight":-0.1856},{"period":"ytd","weight":0.0926}],"description":"Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan.","exchange":"PINK LIMITED","name":"Astellas Pharma, Inc.","nameEN":"Astellas Pharma, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ALPMF\",market:\"US\",,,undefined,":null}}